There is an increase in number of chronic and degenerative diseases around the globe which is making people more aware of their health along with applications of the stem cell & regenerative medicine. In addition to that, the growing rate of geriatric population is resulting in increased cases of diabetes, which is furthering the demand for stem cell and regenerative medicine. Moreover, increased funding on research & development activities on the stem cell and regenerative medicine by government and various industry players will promote the growth of the stem cell and regenerative medicine market in upcoming years.

The global stem cell & regenerative medicine market accounted for USD 10,200.0 Million in 2016 and is believed to reach noteworthy market valuation of USD 14,745.7 Million by the end 2024, expanding at a CAGR of 4.8% between 2017 and 2024.

In terms of regional segmentation, the global stem cell and regenerative medicine market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa. The North America stem cell and regenerative medicine market dominated the market in 2016 and is believed to hold its dominant stance over the forecast period owing to the presence of well-established healthcare industry along with expanded funding from the government organizations. Europe is expected to cross 25% of the total market share by 2024, whereas, the rising adoption of advanced healthcare technologies by consumers is expected to positively impact the growth of the market in Asia Pacific region.

The global stem cell and regenerative medicine market is further segmented by application into regenerative medicine and drug discovery & development. The drug discovery and development segment is believed to dominate the market with a Y-O-Y growth rate of 5.5% in the year 2024.

The Report titled “Global Stem Cell & Regenerative Medicine Market Outlook: Industry Demand Analysis & Opportunity Assessment 2016–2024” also includes some prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market share comparisons, BPS analysis, SWOT analysis and Porter’s five force model.

This report also studies existing competitive scenario of some of the key players of the global stem cell & regenerative medicine market which includes profiling of Sangamo Therapeutics, Pluristem Therapeutics, BIOTIME Inc., Takara Bio Inc., Cellular Engineering Technologies Inc., Thermo Fisher Scientific Inc., Athersys Inc., Osiris Therapeutics Inc., STEMCELL Technologies Inc. and AMAG Pharmaceuticals Inc.

The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the report titled “Global Stem Cell & Regenerative Medicine Market Outlook 2024”, analyses the overall stem cell & regenerative medicine industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the global stem cell & regenerative medicine market in the near future.